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Abstract
Introduction. Prevalence of the lymph node metastases of central neck compartment in papillary thyroid carcinoma (PTC) and its correlation with
regional metastatic remains high. There are pros and cons on central neck dissection which is thought to solve the problem. Selection of appropriate
patient to undergo central neck dissection is then essential. Thus, predictive factors were very useful in such selection, and we run a study aimed to
find out the clinicopathological predictive factors for metastases of central compartment in subjects treated in Cipto Mangunkusumo General
Hospital.
Method. Data of 62 cN0 papillary thyroid carcinoma (PTC) subjects who underwent central neck dissection were collected consecutively and
retrospectively studied. The correlations between clinicopathological factors such as age. Gender, tumor size, extra thyroid extension. Distant
metastasis, completeness of resection, histopathology variant, lymphovascular invasion and central compartment metastases were the variables
analyzed. Chi square. Fischer exact and stratification test were used. Significance found if p value of <0.05 with 95% confidence interval.
Results. In this study, the prevalence in our hospital is 20.9%. The clinicopathological factors that statistically showed significance were the positive
lymphovascular invasion (OR=14.40; p<0.05), tall cell variant (OR= 14.00; p <0.05), positive extra thyroid extension (OR=10.44; p<0.05) and
age ≥45 years (OR= 9.47; p <0.05). Lymphovascular invasion showed a higher OR (OR=14.40).
Conclusion. The lymphovascular invasion, tall cell variant, extra thyroidal extension and age might be the predictors for central compartment
lymph node metastases in cN0 PTC patients. However, lymphovascular invasion has the highest risk factor for central neck compartment
metastases.
Keywords: Papillary thyroid carcinoma cN0, central compartment, central neck dissection

Introduction
Papillary thyroid carcinoma (PTC) is the most found thyroid
carcinoma. The prevalence is up to 75% of all thyroid malignancies
and more than 90% of all well differentiated thyroid carcinoma.1 PTC
mostly give the feature of slow–growing tumors with a good
prognosis. The average of 10–year survival rate was 90%.
Unfortunately the regional metastasis to the lymph nodes (LN) in
neck area is quite common (90%); while as distant metastases is quite
rare found (4%).2 In the central compartment, which is the first
location of the metastatic pathway of PTC to the regional LN,
metastasis is found as much as 80%.3As the regional LN metastasis
prevalence is of a great possibility, high regional recurrence is then
quite high (30%).2 This high rate of regional recurrence becomes an
important issue in terms of increasing the morbidity and mortality of
PTC,3.4 i.e. 30% and1.6%. respectively.5 The involvement of regional
LN increases the risk of death by 46%.6 Therefore, to improve overall
survival a good management of PTC is required to control the
regional metastasis adequately.
Following the respect of the American Thyroid Association, British
Thyroid Association and the European Thyroid Association, Medical
centers in the United States and Europe argued that the management
of PTC that addressed to control regional metastasis could be
achieved by a combination of total thyroidectomy and the

administration of ablative radioiodine and suppression of thyroid
stimulating hormone (TSH) postoperatively. Meanwhile, centers in
Japan implements the recommendations of the Japanese Society of
Thyroid Surgeons and Japanese Association of Endocrine Surgeons
2011, where they were routinely performed the central prophylactic
compartment dissection (CPCD) in patients with thyroid carcinoma,
as the strategy to control the regional metastasis; and followed by the
increased of recurrence–free survival as well as overall survival rate.
Total thyroidectomy and CPCD is carried out in one step, to achieve
the goal which is a better loco regional control.6.7
Somehow, the procedure shows both of advantages and
disadvantages. The selection of appropriate and adequate treatment
resulted in more than 90% average of survival rate.1 CPCD showed
the advantage in achieving a greater control of regional
metastasis.1Such a procedure can be implemented in a rural hospital
in Indonesia where the radio–ablative facility was unavailable. On the
other side, the procedure is followed by risks. Hypoparathyroidism
and laryngeal nerve injury (7% and 5.5%. respectively) were the risks
followed by increased of morbidity.8.9 By this mean, CPCD is then
indicated selectively to those who were predicted where metastasis in
the LN of central compartment is to be found.
Studies in Korea, China, and Japan that run out identifying these
predicting factors of metastatic regional lymph nodes showed a
8

Table 2. Variables of predicting factors
Variables
N
%
Variables
Age (years)
Completeness of
resection
33
53.3 Incomplete
− <45
29
46.7 Complete
− ≥45
Gender
Histopathological
variants
Male
9
14.5 Classic
Female
53
85.5 Follicular
Tumor size
Micro–carcinoma
20
32.3 Tall cell
− <4 cm
42
67.7
− ≥4 cm
Extra thyroid
Vascular–lymph
extension
invasion
6
9.7
Positive
− Positive
56
90.3 Negative
− Negative
Distant metastasis
Central lymph nodes
metastasis
4
6.5
Positive
− Positive
58
93.5 Negative
− Negative

plenty number of factors, namely age, gender, tumor size, extra
extensive thyroid, the presence of distant metastases, and
completeness of the resection, and variants of histopathology and
invasion of vascular–lymph.2.3.7.9
Unfortunately, studies addressed to these predicting factors in patients
– with our characteristics – managed in Cipto Mangunkusumo
General Hospital were never been run yet. We do believe that such a
study is required to find out the clinical predicting factors. Should
these factors be identified, then it will be useful in patient selection
where CPCD is indicated.

Method
A retrospective study conducted with consecutive sampling enrolling
those with PTC's cN0 who underwent CPCD during period of
January 2014 to July 2015. Those with previous thyroid surgery and
those with insufficient data in the medical record were excluded. The
correlation between above mentioned variables were statistically
analyzed. Chi square or Fisher, t–test and stratification test were
carried out. Significance met when p value is <0.05 with 95%
confidence intervals. Ethical committee of FMUI and approved the
study (718/UN2.F1/ETIK/2015) and research bureau of dr. Cipto
Mangunkusumo General Hospital (LB.02.01/X.2/648/2015).

Table1. Subjects’ characteristic on the study
Variable
Mean (±SD)
Age (years)
48.5 (±8.5)
Body weight (kg)
61.5 (±10.5)
Height (m)
1.55 (±0.06)
BMI (kg/m2)
25.43 (±4.08)
Length of stay (days)
4.6 (±1.5)
Total seroma (mL)
502.3(±207.8)
Daily seroma (mL)
109..6 (±32.1)
BMI body mass index.

Median
49
60
1.55
25.39
4
504
106.7

Min–Max
33–69
40–90
1.43–1.77
16.65–35.59
3–8
134–990
44.7–170.8

Factors that showed correlation with LN metastasis were positive
vascular–lymph invasion (OR 14.40), tall cell variant (OR 14.00),
positive extra thyroid extensions (OR 10.44) and age more than 45
years old (OR 9.47), respectively (table 2).
We found there were four variables indicated statistically significant
correlation with metastasis that unable to be analyzed using
multivariate analysis, due to the number of central compartment
metastasis output in the study consists only 13 subjects. Thus, only a
variable allowed to be included into the multivariate model.

%

5
57

8.1
91.9

8
34
5
15

12.9
54.8
8.1
24.0

4
58

6.5
93.5

13
49

20.9
79.1

In addition, tumor size which is analyzed categorically, was also
analyzed numerically. Correlation between tumor sizes with the
incidence of central compartment metastasis showed p 0.52 (table 3).
To determine the independent association between the age and other
variables, we run stratified analyzes based on other factors in the
bivariate analysis. This was found showing a significant correlation
with metastasis. On the stratification of vascular–lymph invasion and
its variants, OR value of age was found consistent (table 4 and 5).

Results
There were 62 subjects enrolled in the study. Mostly (33 subjects,
53.3%) they were under 45 years old, and 53 (85.5%) were females.
We found 42 subjects (67.7%) with tumor sized larger than 4 cm. The
extension of extra thyroid found in six (6.7%) subjects. Distant
metastases was found in four (6.5%) subjects. There were 57 (91.9%)
subjects underwent a complete resection (completeness of positive
resection) namely total thyroidectomy, and the rest 5 (8.1%)
underwent incomplete resection (completeness of negative
resection), namely near total thyroidectomy. The variant of
histopathology most commonly found was follicular (34 subjects,
54.8%), tall cell (15 subjects, 24.0%), the classic variant (8
subjects.12.9%) and micro–carcinoma (5 subjects, 8.1%). There
were four (6.5%) subjects with vascular–lymph invasion. Out of 62
subjects, the central compartment LN metastasis were found in 13
subjects (20.9%) (table 1).

N

Table 3. Correlation of variables with the central compartment metastasis
LN meta
LN meta
OR (CI 95%)
(+)
(–)
Age (years)
- ≥45
11 (37.9%)
18 (62.1%)
9.47
(1.88–47.61)
- <45
2 (6.1%)
31 (93.9%)

−
−
−
−

Gender
- Female
11 (20.8 %)
- Male
2 (22.2 %)
Tumor size
- ≥4 cm
10 (23.8 %)
- <4 cm
3 (15.0 %)
Extra thyroid extension
4 (66.7 %)
- Positive
9 (16.1 %)
- Negative
Distant metastasis
2 (50.0 %)
- Positive
11 (19.0 %)
- Negative
Completeness of Resection
- Complete
10 (17.0 %)
- Incomplete
3 (60.0 %)
Histopathological variants
- Follicular

p

*0.01a

42 (79.2%)
7 (77.8 %)

0.91
(0.16–5.04)

1.00b

32 (76.2 %)
17 (85.0 %)

1.77
(0.42–7.31)

0.52b

2 (33.3 %)
47 (83.9 %)

10.44
(1.65–65.83)

*0.01b

2 (50.0 %)
47 (81.0 %)

4.27
(0.54–33.75)

0.19b

47 (82.5 %)
2 (40.0 %)

0.14
(0.21–0.96)

0.06b

0.21
(0.01–3.81)
14.00
(1.33–147.42)
1.75
(0.08–36.29)

0.29b

1 (2.9 %)

33 (97. %)

- Tall cell

10 (66.7 %)

5 (33.3 %)

- Micro–ca

1 (20.0 %)

4 (80.0 %)

- Classic
1 (12.5 %)
Vascular–lymph invasion
- Positive
3 (75.0 %)
- Negative
10 (17.2 %)

7 (87.5 %)
1 (25.0 %)
48 (82.8 %)

14.4
(1.35–153.04)

*0.03b
0.71b

*0.03b

Table 4. Tumor size correlation with lymph nodes central compartment metastasis
Tumor size

Variables

n

Mean

SD

Positive lymph nodes

13

3.91

3.57

Negative lymph nodes

49

3.57

3.41

p
0.77

9

ILV positive

ILV negative

Table 5. Correlation between age factor with vascular–lymph invasion and metastasis of
central lymph nodes
LN meta LN meta
ILV Age
Total
OR(CI 95%)
p
(–)
(+)
<45
30
0
30
62.5%
0%
51.7%
≥45
18
10
28
37.5%
100 %
48.3%
48
10
58
17.95
Total
0.001
(2.14–150.31)
100%
100%
100%
<45
1
2
3
100%
66.7%
75%
≥45
0
1
1
0%
33.3%
37.5%
1
3
4
1.33
Total
1
(0.07–26.62)
100%
100%
100%
Table 6. Correlation between age with variants and metastasis of central lymph nodes
LN meta LN meta
OR(CI
Variants
Age
Total
p
(–)
(+)
95%)
Follicular

<45
≥45
Total

Tall cell

<45
≥45
Total

Micro–
carcinoma

<45
≥45
Total

Classic

<45
≥45
Total

21

0

21

63.60%
12
36.40%
33

0%
1
100.00%
1

61.80%
13
38.20%
34

100.00%

100.00%

100.00%

5
100.00%
0
0%
5

1
10.00%
9
90.00%
10

6
40.00%
9
60.00%
15

100.00%

100.00%

100.00%

2
50.00%
2
50.00%
4

0
0%
1
100.00%
1

2
40.00%
3
60.00%
5

100.00%

100.00%

100.00%

3
44.40%
4
57.10%
7

1
100.00%
0
0%
1

4
50.00%
4
50.00%
8

100.00%

100.00%

100.00%

3.39
(0.27–
41.08)

0.55

30
(2.21–
405.98)

<0.01

2
(0.11–
35.80)

1

0.4
(0.03–
6.18)

1

Discussion
In our study, the age and gender of enrolled subjects were found
consistent to the findings of studies in Asia (China and South
Korea).3.8 The prevalence of LN metastasis of the central
compartment in the study was of 20.9%, which is found lower than
those reported by Chen (84.3% and 54.1%), and Koo.3.8 However, it
showed no difference to study of Anand in Canada (20%).10 Subjects’
characteristics were also like those reported by Chen, Koo and
Anand: most subjects' age were over 45 years old, predominated by
female, and tumor size were mostly larger than one cm. The
difference in the prevalence of output found in the study was
allegedly due to the difference in the number of samples enrolled.
Study of Chen enrolled of 153 subjects with a study span for three
years. Likewise, formerly Koo enrolled of 111 subjects in a three
years’ study period (2005–2007), while as Anand enrolled a smaller
number of samples (70 subjects).
The aggressiveness type of variant, particularly tall cells, might be
rolled out in the prevalence. However, the variants were unable to be
analyzed in the study, as this variable wasn’t enclosed in the former
study of Chen, Koo and Anand. Subjects’ age was a variable strongly

associated with the incidence of metastases in the LN central
compartment (p<0.05). This is consistent to related literatures that
stated that the age factor is an independent one for the occurrence of
lymph nodes metastasis.11.12.13 This is also found consistent with the
published reports that the prognosis is worsening in those over 45
year’s old.12.14.15.16. The prognosis scoring system of Memorial Sloan
Kettering (grade, age, metastases, extent, size abbreviated with
mnemonic of GAMES) and American Joint Committee on Cancer
Tumor Nodal Metastasis (AJCC TNM) categories patients over 45
years old into the high risk group for the recurrence and low survival
rate category.17.18 In accordance to the AJCC TNM system, patients
under 45 years old were categorized into stage one or two, while as
subjects of 45 years old and above were categorized into stage three
or four. Consequently, these subjects were categorized of high risk
group with low survival rate. Estrogen exposure and the mutation of
thyroid's beta receptor (TRβ) were responsible factors for the
aggressiveness, in which is depends on age.19 Based on the
stratification, our study showed that age indicates the tendency of
independent association with the incidence of metastasis; when it is
linked to tall cell variant.
Gender in our study showed no correlation with the central
compartment LN metastasis (p = 1.00). However, in male subjects
we found slightly higher metastases in the central compartment (22%
versus 20.8% in female). We found in the publication that the
prognosis in male is poor rather than female,8 since estrogen referred
to the factor affects the LH secretion through feedback mechanism.
However, with low estrogen level found in male this impact is quite
minimal. In our study, we found no significant correlation with this
gender factor which is likely due to the number in the outputs of
central lymph nodes metastasis that is quite small.20.21
Tumor size seems to be a factor tends to be correlated with the
incidence of metastasis. Tumor size of ≥4 cm was found in 23.8%
subjects and metastasized to the central lymph nodes, compared to
15% tumor size of <4 cm. Still, this correlation showed no statistically
significance in our study (p 0.52). The low total output and uneven
distribution were assumed to be responsible to insignificant
correlation with metastatic LN in the central compartment. Tumor
size was numerically analyzed as well and showed no significance
correlation (p 0.77). In published reports, tumor size referred to
variable correlated with the outcomes in papillary thyroid carcinoma.
In accordance to AJCC TNM, tumor size >4 cm is followed by
increased of mortality. Larger tumor size often accompanies both of
regional and distant metastases. A published study reported that
tumor size of <1 cm is seldomly correlated with mortality.
The mortality rate in the study ranged of 0 to 2.2% and the risk of
recurrence and cancer–specific mortality rate increases with increase
of tumor size. Tumor sized of <1.5 cm showed average of cancer–
specific mortality of 30 years (0.4%) compared to 22% in tumor sized
of >4.5 cm.22 However, a study reported that tumor size may not
associated independently with the recurrence rates.
Aggressive variants such as tall cell and their extensions is likely
affects the extra thyroid recurrence.17 In our population, mostly
subjects of papillary thyroid carcinoma presented with tumor sized of
>2 cm. In the study there were just two subjects with tumor sized of
<2 cm (3.2%),the tumor sized of ≥4 cm found in 67.7%. With these
small number of subjects with <2 cm tumor, it was necessarily an
obstacle to conduct statistical analysis. Future study is required to find
out the correlation between tumor size and the incidence of central
compartment LN metastasis. Including the subjects with tumor sized
of <2 cm and considering the variants as well as extensions of extra
thyroid, it is expected that tumor size affects the metastasis in the
10

central compartment LN and the independence of the extra thyroid
variants and extensions to be able to be identified.
Extra thyroid extensions in this study showed a statistically
significance correlation with the occurrence of metastases in the
central compartment (p < 0.05). It is in accordance to the published
reports in which the thyroid extra extensions had been identified to
increase the risk of local recurrence.22.23 Extra thyroid extensions is an
important prognostic factor in papillary thyroid carcinoma and
correlated to the recurrence rates with high mortality. The extra
thyroid extensions indicated tumor aggressiveness and significantly
improved the mean mortality by 6–71% with the mean recurrence by
37–64%.24
Distant metastases are a component established in the assessment of
prognosis of MACIS score. According to Koo, it showed correlation
with metastasis in the central compartment LN.8 However, we found
it showed no correlation with central compartment LN metastasis (p
0.19). This just showing that the distant metastases in the study is
more likely to occur due to hematogenic propagation.
Completeness of resection is also a component in MACIS score,
which is in the study found to have correlation with metastasis of
central compartment LN. Out of 60% subjects with incomplete
resection showed metastatic central compartment. While as out of the
subjects experiencing complete resection, there is only 17.5% found.
This suggested that incomplete resection may be correlated with
metastases in central compartment. However, no statistically
significant correlation found (p 0.06), although data indicating that a
complete resection might results in protective effect against
metastasis in the central compartment LN (OR 0.14). Completeness
of resection is influenced by the presence of tumor attachment to the
surrounding tissue of an important structures. Presence of adhesions
indicated tumor infiltrated across the thyroid capsule. In our study, the
extra thyroid extensions were significantly correlated with metastatic
central thyroid compartment LN. Insignificant correlation between
completeness of resection with metastasis in the central compartment
was allegedly due of the small number of samples of subjects who
received incomplete resection (n = 5; 8.1%).
The tall cell variant showed statistically significance correlation with
the central compartment metastasis (p < 0.05). This is found
consistent to the published reports, showed that rather than other
variants the tall cell variant found to have higher central compartment
metastasis. This variant generally accepted as a more aggressive
variant of PTC and possesses a high risk of recurrence. Kazaure
reported such a variant is associated with reducing of five–year
survival rate (80.6% compared 93.5% of classic PTC's).17Aggressive
biological character in the form of higher, more invasive, easily move
and turn to poorly differentiated or anaplastic mitotic count.25 The
overexpression of genetic components such as MUC1, MMP2, Braf
V600E and cMET is thought to be responsible for this specialized
character.25.26.27 Tall cell variant which is first described by Hawk and
Hazard in 1976, defined as a tumor composed by cells with a height
of two to three times its width, with eosinophilic cytoplasm,
bacillary–oriented nucleus and core surface as found in the classic
PTC's. Benninato reported that the variant may covers up 1.3–12%
PTC area. Kazaure found in their study it covered up 3.2–19% PTC
area. Other studies found that such a variant often turned out to be
underdiagnosed. In cases where the tumor was first diagnosed as a
classical variant of PTC, 1–13% evidently referred to tall cell variant
following a reviewed by endocrine pathologist. Another study
reported that 90% tall cell variants have been erroneously classified
or underreported. A potential obstacle in instituting the diagnosis
exactly is the absence of international consensus on the number

criterion of tall cell should be found. A recommendation proposed
30–70% as the cutoff point and the selection is up to the local
institutions. In our Department of Anatomical Pathology, the cutoff
point applied is 50%. In addition, a tumor with tall cells than the cutoff
point consequently defined as PTC with a chance of tall cells. Some
centers recommended that should the tumor contains less than 30%
of tall cell then it should be categorized as classic PTC. Given these
differences, coupled with the lack of data regarding the differences
between clinical features of tumors contained a small number of tall
cells with that of those containing a great number of tall cells, the
diagnostic criteria is considered not universally established yet.
Although some study as Benninato did showed that of 10% tall cell
alone can resulted in aggressive output.13.14
Vascular–lymph invasion showed a statistically significance
correlation with the central compartment LN metastasis (p <0.05).
This is in accordance to the study of Koo et al., reporting that the
invasion of vascular–lymph showed a substantial correlation with
metastasis of PTC's central compartment.8.15 However, in our study
vascular–lymph invasion referred not to an independent factor. The
study found vascular–lymph invasion Odds ratio of 14.40, higher
than the former four factors showed statistically significant
correlation with metastatic central compartment LN. Thus, the
invasion of vascular–lymph in this study referred to the strongest
predicting factor showed from the perspective of the risk it might
have on the central compartment metastasis. The discovery of
vascular–lymph invasion in our study provide the evidence that the
process of metastasis in PTC is in accordance to the theory of
metastasis, in which the tumor cells invade in advance into the lymph
vessels and subsequently invasion to the LN.10.27
Out of the eight factors we studied, there were four factors statistically
showed significant correlation with the occurrence of central
compartment LN metastasis, and thus referred to be a predicting
factor of metastatic LN central compartment. These factors were
positive vascular–lymph invasion, tall cell variant, positive extra
thyroid extensions, and age >45 years old, respectively.
Factor of age can simply be noted prior to the first surgical
intervention. Through macroscopic assessment, extra thyroid
extension can be identified intra operatively in the first surgical
intervention. Microscopic extra thyroid extensions, tall cells variant,
and invasion of vascular–lymph was identified following the first
surgical intervention, which is following the definitive pathological
assessment. Therefore, should the first surgical intervention in a 45
years old papillary thyroid carcinoma subjects macroscopically
found an extra extension of thyroid, then prophylactic central
compartment dissection might be considered. Otherwise, should one
microscopically found extra thyroid extension, tall cell variant,
vascular–lymph invasion following the first surgery, then the patient
can be treated as high–risk subject.
The fundamental thinking is, we should find at least two of the four
factors of prognosis scoring system. Age of 45 is a component that
determines high risk category in the assessment of prognosis per
AJCC TNM and extra thyroid extension on the AMES and MACIS.
While as tall cell is categorized as the high risk one as its
aggressiveness by nature in accordance to guidelines proposed by the
National Comprehensive Cancer Network (NCCN). European
Thyroid Association (ETA) classifies the vascular–lymph invasion
and aggressive types such as tall cell variants as the high-risk group.
Therefore, in patients with identified these four factors, which is high
risk ones, ablative radioiodine therapy with 100–300 mCi (doses for
high risk subjects) that suppress L–tyrosine with a TSH target being
less than 0.1 U/mL and more rigorous postoperative observation
11

focusing on regional recurrence (recurrence in the central
compartment of LN) can be carried out.
In PTC patients of whom a completion will undergo, should the four
factors have found, then a prophylactic central compartment
dissection is advisable. However, technical difficulty of central
compartment dissection in cases of completion is considerably higher
with the possibility of adhesions and fibrotic tissue following the
former surgical intervention. This is somehow leading to increase the
risk of complications particularly hypoparathyroidism is greater in
folds as parathyroid glands hard to be identified. The surgeon’s
experience in this specialized field should be of ones’ consideration.21
Central compartment dissection aimed to achieve a better regional
control remain controversies. The risk and benefit showed in varies.
Therefore, central compartment dissection remains an interesting
topic to be investigated. The predicting factors found in this study can
be applied in selection of patients to precede the prophylactic central
compartment dissection. However, since there’s limited to just two
factors that could be identified in the first surgery (namely, age and
macroscopic extra thyroid extension), expertise is further required to
come up with essential ways to have the better assessment of a central
compartment of LN during the first surgery. LN sentinel biopsy may
be considered in the first surgery. Somehow, a further investigation is
needed to find out the accuracy of sentinel LN biopsy.23.28.29.30

6.

7.
8.
9.

10.

11.

12.

13.

14.

15.

The limitation of this study referred to the number of subjects enrolled
as well as output. Therefore, further study is required. Despite the
shortcomings, this study provides the prevalence of metastasis in
lymph nodes central compartment in this PTC patient managed in
Cipto Mangunkusumo hospital, which might be valuable for further
investigation. Furthermore, the clinically pathological predicting
factors found in this study can be applied in clinical daily practice, as
the consideration in the management of the PTC cN0 patients.

16.

17.

18.

Conclusion
19.

We found vascular–lymph invasion, tall cell variant, extra thyroid
extensions, and age >45 years old were predictor factors showed
significant correlation with metastasis of LN. Prevalence of LN
metastasis in the central compartment on the subjects with PTC cN0
in RSCM was 20.9%.
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